Details for Patent: 7,803,770
✉ Email this page to a colleague
Which drugs does patent 7,803,770 protect, and when does it expire?
Patent 7,803,770 protects TYMLOS and is included in one NDA.
This patent has forty-one patent family members in twenty-seven countries.
Summary for Patent: 7,803,770
| Title: | Method of treating osteoporosis comprising administration of PTHrP analog |
| Abstract: | The present invention provides a storage-stable composition containing a parathyroid hormone-related protein (PTHrP) and methods of using a PTHrP and the PTHrP compositions described herein to treat osteoporosis, to increase bone mass or to increase bone quality. The composition is storage stable, in sterile form, and in general may be stored at room temperature for at least several weeks to allow convenient parenteral administration to human patients. |
| Inventor(s): | Dey; Michael J. (Sandbach, GB), Mondoly; Nathalie (Le Chesnay, FR), Rigaud; Benedicte (Oulins, FR), Henderson; Bart (Belmont, MA), Lyttle; C. Richard (Bala Cynwyd, PA) |
| Assignee: | Radius Health, Inc. (Cambridge, MA) Ipsen Pharma S.A.S. (Boulogne-Billancourt, FR) |
| Application Number: | 12/151,975 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 7,803,770
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radius | TYMLOS | abaloparatide | SOLUTION;SUBCUTANEOUS | 208743-001 | Apr 28, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | METHOD OF TREATING POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT HIGH RISK FOR FRACTURE. | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,803,770
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2073789 | ⤷ Sign Up | 301235 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2073789 | ⤷ Sign Up | CA 2023 00019 | Denmark | ⤷ Sign Up |
| European Patent Office | 2073789 | ⤷ Sign Up | 2023C/523 | Belgium | ⤷ Sign Up |
| European Patent Office | 2073789 | ⤷ Sign Up | LUC00309 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 2073789 | ⤷ Sign Up | 23/2023 | Austria | ⤷ Sign Up |
| European Patent Office | 2073789 | ⤷ Sign Up | 122023000031 | Germany | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
